2.5 ML cyclophosphamide 200 MG/ML Injection — RxCUI 2568663
RxNorm drug concept · Semantic clinical drug
RxCUI 2568663
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2568663
Official name2.5 ML cyclophosphamide 200 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascyclophosphamide 500 MG per 2.5 ML Injection; cycloPHOSphamide 500 MG in 2.5 ML Injection
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,169 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cyclophosphamide Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's a chemotherapy drug — one of the most versatile ones. It treats a number of different cancers including lymphomas like Hodgkin's disease, leukemias, multiple myeloma, breast c...
- What exactly is cyclophosphamide injection used for?
- That's a really important part of your treatment. When cyclophosphamide breaks down in your body, some of its byproducts can irritate and damage the lining of your bladder, sometim...
- Why do I have to drink so much water when I get this infusion?
🕸️ Concept Web — How 2.5 ML cyclophosphamide 200 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2.5 ML cyclophosphamide 200 MG/ML Injection
RxCUI 2568663 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cyclophosphamide
3002IN
-
Cyclophosphamide
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cyclophosphamide Injection
1734916SCDF -
Cyclophosphamide Injectable Product
1156181SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Cyclophosphamide Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cyclophosphamide 200 MG/ML
2386858SCDC
-
Cyclophosphamide 200 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cyclophosphamide 200 MG/ML
SCDC · 2386858 -
Cyclophosphamide Injection
SCDF · 1734916 -
Cyclophosphamide Injectable Product
SCDG · 1156181
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 2568663 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 55150-0270-99 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-270-99) / 2.5 mL in 1... | Cyclophosphamide | Eugia US LLC | 2023-11-20 |
| 55150-0271-99 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-271-99) / 5 mL in 1 V... | Cyclophosphamide | Eugia US LLC | 2023-11-20 |
| 55150-0272-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-272-01) / 10 mL in 1... | Cyclophosphamide | Eugia US LLC | 2023-11-20 |
Observed labelers:
Eugia US LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9071 | Inj cyclophosphamd auromedic | 3 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.